Challenging a Traditional Paradigm
Edward I. Chang(The University of Texas MD Anderson Cancer Center), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center), Eric I. Chang(The University of Texas MD Anderson Cancer Center), Matthew M. Hanasono(The University of Texas MD Anderson Cancer Center), Roman J. Skoracki(The Ohio State University), Naoto T. Ueno(Breast Cancer Care), Hong Zhang(The University of Texas MD Anderson Cancer Center), Melissa A. Crosby(Texas Plastic Surgery), Alexander T. Nguyen(Yale New Haven Health System), Ran Ito(The University of Texas MD Anderson Cancer Center)
Cited by 24
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|Journal of Clinical Oncology|1998|927
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
|Gastroenterology|2000|737